Intraday Stock Market Live News; Nifty fell 9.70 points to 7545.50

                                               www.capitalheight.com/about.php
                                       Call 9993066624

Globally, gold climbed as much as 1.07 percent to USD 1,251.70 an ounce in Singapore today.
           Gold prices rose 0.53 percent to Rs 29,284 per 10 grams in futures trade today as speculators raised their bets, taking positive cues from global markets.Market analysts said rise in gold prices at futures trade was largely in step with a firm trend overseas as global economic-growth concerns boosted the metal's appeal as a haven asset.

                       Sun Pharmaceutical Industries shares gained 2 percent intraday on approval from the US health regulator for anti-inflammatory drug. One of wholly owned subsidiaries of the company, on April 9, received approval from US Food & Drug Administration (USFDA) for new drug application (NDA) related to BromSite (bromfenac ophthalmic solution) 0.075 percent. The drug is used for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery. BromSite, developed by InSite Vision, is the first non-steroidal anti-inflammatory drug (NSAID) approved by the USFDA to prevent pain and treat inflammation in the eye for patients undergoing cataract surgery.

             The soon-to-be launched snow park at Adlabs Imagica is a move towards achieving cash break-even for the company, says Kapil Bagla, CEO of Adlabs Entertainment . Bagla hopes the theme park to break even in FY17. Spread across an area of 30,000 sq ft, the expected footfalls for the snow park is around 3000-4000 per day, which will increase the annual capacity to 15 lakh. The theme park is located just off the Mumbai-Pune Expressway. Bagla expects revenue from the snow park to be around Rs 15-18 crore, and says it would contribute about 25 percent to the total Adlabs business.